Worth Venture Partners, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 10 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$182,000
-38.5%
42,887
-59.5%
0.15%
-18.1%
Q1 2020$296,000
-50.1%
105,842
-13.4%
0.18%
-37.2%
Q4 2019$593,000
+101.7%
122,156
-13.9%
0.29%
+72.6%
Q3 2019$294,000
-55.3%
141,801
+7.0%
0.17%
-53.8%
Q2 2019$657,000
+20.8%
132,514
+10.6%
0.36%
+20.1%
Q1 2019$544,000
+44.3%
119,863
-7.7%
0.30%
+6.3%
Q4 2018$377,000129,8630.28%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders